NYSE: FOLD - Amicus Therapeutics, Inc.

Yield per half year: -16.74%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Amicus Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc., биотехнологическая компания, занимается открытием, разработкой и коммерциализацией методов лечения целого ряда редких и орфанных заболеваний. Компания предлагает Галафолд, перорально вводимый фармакологический компаньон с малой молекулой для лечения болезни Фабри. Он также проводит фазу 3 (ATB200-03) клинического исследования AT-GAA для болезни Помпе. Компания имеет соглашения о сотрудничестве и лицензии с Национальной детской больницей и Университетом Пенсильвании. Amicus Therapeutics, Inc. была основана в 2002 году со штаб-квартирой в Крэнбери, штат Нью-Джерси.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2007-05-31
ISIN US03152W1099
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://amicusrx.com
Цена ао 9.55
Change price per day: 0% (9.55)
Change price per week: -2.85% (9.83)
Change price per month: +3.69% (9.21)
Change price per 3 month: -5.35% (10.09)
Change price per half year: -16.74% (11.47)
Change price per year: -27.54% (13.18)
Change price per 3 year: +0.3151% (9.52)
Change price per 5 year: -27.43% (13.16)
Change price per 10 year: -22.04% (12.25)
Change price per year to date: -2.25% (9.77)
All parameters

Underestimation

Title Value Grade
P/S 10.05 1
P/BV 25.06 1
P/E 0 0
EV/EBITDA -64.19 0
Total: 2

Efficiency

Title Value Grade
ROA, % -19.49 0
ROE, % -94.64 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -6.04 10
Total: 7.8

Growth impulse

Title Value Grade
Yield Revenue, % 119.19 10
Yield Ebitda, % -72.01 0
Yield EPS, % -65.3 0
Total: 2
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
02.12.2024 03.12.2024 Campbell Bradley L
President and CEO		 Sale 10.02 75 150 7500 0 0 link
02.12.2024 03.12.2024 Campbell Bradley L
President and CEO		 Purchase 8.61 64 575 7500 0 0 link
01.11.2024 04.11.2024 Campbell Bradley L
President and CEO		 Sale 11.46 85 950 7500 0 0 link
01.11.2024 04.11.2024 Campbell Bradley L
President and CEO		 Purchase 8.61 64 575 7500 0 0 link
01.10.2024 04.10.2024 Campbell Bradley L
President and CEO		 Sale 10.6 79 500 7500 0 0 link
01.10.2024 04.10.2024 Campbell Bradley L
President and CEO		 Purchase 8.61 64 575 7500 0 0 link
03.09.2024 03.09.2024 BRADLEY CAMPBELL
Director		 Purchase 11.61 87 075 7500 0 0 link
01.08.2024 05.08.2024 Campbell Bradley L
President and CEO		 Sale 10.34 77 550 7500 0 0 link
01.08.2024 05.08.2024 Campbell Bradley L
President and CEO		 Purchase 8.61 64 575 7500 0 0 link
10.01.2024 11.01.2024 Crowley John F
Executive Chairman		 Sale 13.65 431 531 31614 0 -0.01 link
09.01.2024 09.01.2024 Prout Samantha
Chief Accounting Officer		 Sale 14 18 718 1337 0 0 link
09.01.2024 09.01.2024 Clark David Michael
Chief People Officer		 Sale 14 19 376 1384 0 0 link
08.01.2024 09.01.2024 Prout Samantha
Chief Accounting Officer		 Sale 14 430 738 30767 0 -0.01 link
08.01.2024 09.01.2024 Clark David Michael
Chief People Officer		 Sale 14 122 164 8726 0 0 link
02.01.2024 04.01.2024 Campbell Bradley L
President and CEO		 Sale 14.23 225 304 15833 0 -0.01 link
15.09.2023 18.09.2023 Crowley John F
Executive Chairman		 Sale 13.06 78 935 6044 0 0 link
01.06.2023 05.06.2023 Campbell Bradley L
President & CEO		 Sale 11.36 132 912 11700 0 0 link
01.06.2023 05.06.2023 Campbell Bradley L
President & CEO		 Purchase 2.64 30 888 11700 0 0 link
01.06.2023 05.06.2023 Crowley John F
Executive Chairman		 Sale 11.36 68 660 6044 0 0 link
17.03.2023 21.03.2023 RAAB MICHAEL
Director		 Sale 11.33 49 943 4408 0 0 link
18.01.2023 19.01.2023 Quimi Daphne
Chief Financial Officer		 Sale 13 89 999 6923 0 0 link
18.01.2023 19.01.2023 Clark David Michael
Chief People Officer		 Sale 13.5 99 657 7382 0 0 link
17.01.2023 19.01.2023 Quimi Daphne
Chief Financial Officer		 Sale 12.49 62 450 5000 0 0 link
13.01.2023 17.01.2023 MCGLYNN MARGARET G
Director		 Sale 13.03 195 450 15000 0 -0.01 link
13.01.2023 17.01.2023 MCGLYNN MARGARET G
Director		 Purchase 3.32 49 800 15000 0 0.01 link
15.12.2022 19.12.2022 Crowley John F
Executive Chairman		 Sale 12.15 127 186 10468 0 0 link
01.12.2022 05.12.2022 Campbell Bradley L
President & CEO		 Sale 12.2 66 917 5485 0 0 link
01.12.2022 05.12.2022 Campbell Bradley L
President & CEO		 Purchase 3.53 19 362 5485 0 0 link
01.12.2022 05.12.2022 Crowley John F
Executive Chairman		 Sale 12.2 138 433 11347 0 0 link
01.11.2022 03.11.2022 Campbell Bradley L
President & CEO		 Sale 10.01 54 755 5470 0 0 link
01.11.2022 03.11.2022 Campbell Bradley L
President & CEO		 Purchase 3.53 19 309 5470 0 0 link
01.11.2022 03.11.2022 Crowley John F
Executive Chairman		 Sale 10.32 117 091 11346 0 0 link
21.06.2022 22.06.2022 Rosenberg Ellen
Chief Legal Officer		 Sale 10 111 220 11122 0 0 link
21.06.2022 22.06.2022 Campbell Bradley L
Chief Operating Officer		 Sale 10 164 100 16410 0 -0.01 link
21.06.2022 22.06.2022 Campbell Bradley L
Chief Operating Officer		 Purchase 3.53 57 927 16410 0 0.01 link
02.05.2022 04.05.2022 RAAB MICHAEL
Director		 Sale 6.99 104 850 15000 0 -0.01 link
02.05.2022 04.05.2022 RAAB MICHAEL
Director		 Purchase 4.79 71 850 15000 0 0.01 link
02.05.2022 04.05.2022 MCGLYNN MARGARET G
Director		 Sale 6.99 104 850 15000 0 -0.01 link
02.05.2022 04.05.2022 MCGLYNN MARGARET G
Director		 Purchase 4.79 71 850 15000 0 0.01 link
07.04.2022 08.04.2022 Rosenberg Ellen
Chief Legal Officer		 Sale 9.06 99 823 11018 0 0 link
18.01.2022 19.01.2022 Crowley John F
Chairman & CEO		 Sale 10.23 87 610 8564 0 0 link
01.10.2021 04.10.2021 WHITMAN BURKE W
Director		 Purchase 9.56 14 340 1500 0 0 link
15.04.2021 19.04.2021 Crowley John F
Chairman & CEO		 Sale 10.09 221 980 22000 0 -0.01 link
15.04.2021 19.04.2021 Crowley John F
Chairman & CEO		 Purchase 6.45 141 900 22000 0 0.01 link
01.12.2020 03.12.2020 WHITMAN BURKE W
Director		 Purchase 23.5 35 250 1500 0 0 link

Institutions Volume Share, %
Vanguard Group Inc 28492486 9.65
Perceptive Advisors LLC 28057456 9.5
Avoro Capital Advisors LLC 27400000 9.28
Blackrock Inc. 22988139 7.78
JP Morgan Chase & Company 17848531 6.04
Wellington Management Group, LLP 15190024 5.14
Redmile Group, LLC 14828321 5.02
Morgan Stanley 13327897 4.51
State Street Corporation 13163085 4.46
William Blair Investment Management, LLC 11647026 3.94

ETF Share, % Profitability for 1 year, % Dividends, %
Virtus LifeSci Biotech Products ETF 1.49718 36.79 0.13953
Global X Guru Index ETF 1.42436 38.91 0.71623
WisdomTree BioRevolution Fund 1.29837 -4.69 0.78691
First Trust Innovation Leaders ETF 1.05119 45.14 0.51521
Direxion Daily S&P Biotech Bull 3x Shares 0.41982 4067.92 0.25924
Future Tech ETF 0.32442 426.34 0.8416
Principal Healthcare Innovators ETF 0.32442 618.5 0.8416
ProShares UltraShort Nasdaq Biotechnology 0.32 -40.36 1.76
Invesco Nasdaq Biotechnology ETF 0.31382 28.58 0.8565
Vanguard Russell 2000 Growth ETF 0.25 23.05 0.60264
iShares Russell 2000 Growth ETF 0.24458 38.04 0.6026
ProShares Ultra Nasdaq Biotechnology 0.21475 51.7 0.85651
Inspire Small/Mid Cap ETF 0.20263 28.65 1.92038
BNY Mellon US Small Cap Core Equity ETF 0.15909 30.07 1.75333
Vanguard Russell 2000 ETF 0.13 17.16 1.48801
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.09936 31.36 1.41955
First Trust Long/Short Equity ETF 0.09004 17.29 1.96644
iShares Morningstar Small-Cap Growth ETF 0.08878 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.08878 587.89 0.72598
Schwab U.S. Small-Cap ETF 0.07786 17.47 1.51433
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF 0.07666 21.79 1.42082
ProShares UltraPro Russell2000 0.07157 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.06446 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.06446 391.25 1.60498
iShares Morningstar Small Cap Value ETF 0.0394 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.0394 201.65 2.50476
Fidelity MSCI Health Care Index ETF 0.03675 3 1.46057
ProShares Hedge Replication ETF 0.01955 5.92 1.47892
Humankind US Stock ETF 0.01564 18.81 1.99919
Vanguard Russell 3000 ETF 0.01 31.87 1.43817
Vanguard ESG U.S. Stock ETF 0.01 23.54 1.26927
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.00992 17.58 1.75869
iShares Russell 3000 ETF 0.00614 24.83 1.43482
Schwab U.S. Broad Market ETF 0.00533 24.86 1.43354
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00406 21.94 1.69572



Head Job title Payment Year of birth
Mr. Bradley L. Campbell M.B.A. CEO, President & Director 984.09k 1976 (49 years)
Ms. Ellen S. Rosenberg Chief Legal Officer & Corporate Secretary 733.94k 1963 (62 years)
Ms. Samantha Prout Chief Accounting Officer & Controller N/A 1978 (47 years)
Andrew Faughnan Senior Director of Investor Relations N/A
Mr. David M. Clark Chief People Officer 701.39k 1976 (49 years)
Dr. Jill Weimer Ph.D. Chief Science Officer N/A
Mr. Simon Nicolas Reade Harford Chief Financial Officer N/A 1960 (65 years)
Mr. Patrik S. Florencio Esq. Global Chief Compliance & Risk Officer N/A
Ms. Diana Moore Head of Global Corporate Communications N/A
Dr. Jeffrey P. Castelli Ph.D. Chief Development Officer 1972 (53 years)

Address: United States, Philadelphia, PA , 3675 Market Street - open in Google maps, open in Yandex maps
Website: http://amicusrx.com